bionomics-rgb-1024px.png
Bionomics to Participate in Upcoming September Investor Conferences
31 août 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
bionomics-rgb-1024px.png
Bionomics reports Full Year Financial Results
25 août 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq:BNOX), today announced its financial results for the 12 months ended 30 June 2022. Bionomics is a clinical...
bionomics-rgb-1024px.png
Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M
08 août 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, NASDAQ:BNOX), a clinical stage biopharmaceutical company, is pleased to announce that the Company has received...
bionomics-rgb-1024px.png
Quarterly Activities Report for June 2022
29 juil. 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, July 29, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a global, clinical stage biopharmaceutical company, today released its...
bionomics-rgb-1024px.png
Bionomics to Participate in William Blair’s Biotech Focus Conference 2022
08 juil. 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, July 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
bionomics-rgb-1024px.png
Bionomics Limited to Participate in the H.C. Wainwright Mental Health Conference
27 juin 2022 06h00 HE | Bionomics Ltd
ADELAIDE, Australia, June 27, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
bionomics-rgb-1024px.png
Bionomics Investor Webinar
13 juin 2022 16h30 HE | Bionomics Ltd
ADELAIDE, Australia, June 13, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO |Nasdaq: BNOX ), (Bionomics or the Company), a clinical-stage biopharmaceutical company developing novel,...
bionomics-rgb-1024px.png
Bionomics' Half-Year Report
23 févr. 2022 21h00 HE | Bionomics Ltd
ADELAIDE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), today announced its half-year report for the half-year ended 31 December 2021. The half-year ending...